B.1.526 SARS-CoV-2 variants identified in New York City are...

Main
B.1.526 SARS-CoV-2 variants identified...

B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies

0 / 0

Avez-vous aimé ce livre?

Quelle est la qualité du fichier téléchargé?

Veuillez télécharger le livre pour apprécier sa qualité

Quelle est la qualité des fichiers téléchargés?

Année:

2021

Fichier:

PDF, 1.96 MB

IPFS:

,

2021

Télécharger (pdf, 1.96 MB)

La conversion en est effectuée

La conversion en a échoué

Cela peut vous intéresser

William A. Haseltine — Variants! The Shape-Shifting Challenge of COVID-19

Piyush Gupta — Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag

— New Scientist

unknown — Science

unknown — Science

AAAS — Science

Nouara Yahi & Henri Chahinian & Jacques Fantini — Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?

... — New Scientist

... — New Scientist

Dr. Sherri Tenpenny — 20 Mechanisms of Injuries (MOI) - How COVID-19 Injections Can Make You Sick; Even Kill You

— A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model

Baxamusa, Salmaan H. — Quantitative form and fit of N95 filtering facepiece respirators are retained and coronavirus surrogate is inactivated after heat treatments

wangke — SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Administrator — Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients

Youchun Wang — Pseudotyped Viruses

Michael Palmer, Sucharit Bhakdi, Brian Hooker, Mary Holland, Margot DesBois, David Rasnick, Catherine Austin Fitts — mRNA Vaccine Toxicity

— Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response

— Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

— Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals

— Evolution of antibody immunity to SARS-CoV-2

Jinyong Zhang, Hao Zeng, Jiang Gu, Haibo Li, Lixin Zheng — Progress and Prospects on Vaccine Development against SARS-CoV-2

Mark Yarmarkovich, John M. Warrington, Alvin Farrel, John M. Maris — A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity

Kevin Dick, Kyle K. Biggar, James R. Green — Computational Prediction of the Comprehensive SARS-COV-2 Vs. Human Interactome to Guide the Design of Therapeutics

Po Ying Chia, Kristen Kelli Coleman, Yian Kim Tan, Sean Wei — Detection of Air and Surface Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospital Rooms of Infected Patients

Matteo Chiara, David S. Horner, Graziano Pesole — Comparative genomics suggests limited variability and similar evolutionary patterns between major clades of SARS-Cov-2

Zhe Liu, Huanying Zheng, Runyu Yuan, Mingyue Li — Identification of a common deletion in the spike protein of SARS-CoV-2

Amaka Ubani, Francis Agwom, Nathan Yakubu Shehu — Molecular Docking Analysis Of Some Phytochemicals On Two SARS-CoV-2 Targets

Jacob Kames, David D. Holcomb, Ofer Kimchi, Michael DiCuccio — Sequence analysis of SARS-CoV-2 genome reveals features important for vaccine design

Neha Jain, Uma Shankar, Prativa Majee, Amit Kumar — Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopes

Leon Fodoulian, Joel Tuberosa, Daniel Rossier — SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium

Qiang Zhang, Huajun Zhang, Kun Huang, Yong Yang — SARS-CoV-2 neutralizing serum antibodies in cats: A serological investigation

Katie M. Campbell, Gabriela Steiner, Daniel K. Wells — Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles

Chek Meng Poh, Guillaume Carissimo, Bei Wang — Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein

Mots Clefs